These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Biochemical and immunologic diagnosis of cancer. Urinary immunocytology and bladder carcinomas. Arndt R; Huland H Tumour Biol; 1987; 8(2-3):105. PubMed ID: 3448761 [No Abstract] [Full Text] [Related]
5. Biochemical and immunologic diagnosis of cancer. Melanoma. Cordon-Cardo C Tumour Biol; 1987; 8(2-3):151-5. PubMed ID: 3329398 [No Abstract] [Full Text] [Related]
6. Biochemical and immunologic diagnosis of cancer. Central nervous system tumors. Collins VP Tumour Biol; 1987; 8(2-3):147-50. PubMed ID: 3329397 [No Abstract] [Full Text] [Related]
7. Biochemical and immunologic diagnosis of cancer. Neuroblastoma. Collins VP; Cordon-Cardo C Tumour Biol; 1987; 8(2-3):143-6. PubMed ID: 3329396 [No Abstract] [Full Text] [Related]
8. Multiple cell markers in bladder cancer. Principles and clinical applications. Javadpour N Urol Clin North Am; 1984 Nov; 11(4):609-16. PubMed ID: 6390912 [TBL] [Abstract][Full Text] [Related]
9. Biological markers of prognosis in invasive bladder cancer. Fradet Y Semin Oncol; 1990 Oct; 17(5):533-43. PubMed ID: 2218565 [No Abstract] [Full Text] [Related]
10. [Behavior of ABH surface antigens in superficial and invasive bladder neoplasma: inferences for the mechanism of tumor progression]. Srougi M; Alves VA; Gayotto LC; Arap S Rev Hosp Clin Fac Med Sao Paulo; 1986; 41(1):24-7. PubMed ID: 3547591 [No Abstract] [Full Text] [Related]
11. [Prognostic evaluation of patients with cancer of the bladder by detection of ABH surface antigens]. Srougi M; Alves VA; Gayotto LC; Raia S; Arap S AMB Rev Assoc Med Bras; 1987; 33(3-4):67-70. PubMed ID: 3501142 [No Abstract] [Full Text] [Related]
12. Carbonic anhydrase IX in bladder cancer: a diagnostic, prognostic, and therapeutic molecular marker. Klatte T; Seligson DB; Rao JY; Yu H; de Martino M; Kawaoka K; Wong SG; Belldegrun AS; Pantuck AJ Cancer; 2009 Apr; 115(7):1448-58. PubMed ID: 19195047 [TBL] [Abstract][Full Text] [Related]
13. Alterations in antigen expression in superficial bladder cancer. Grossman HB; Washington RW; Carey TE; Liebert M J Cell Biochem Suppl; 1992; 16I():63-8. PubMed ID: 1305690 [TBL] [Abstract][Full Text] [Related]
14. [Recurrent urological cancer--diagnose and treatment]. Takeshima H; Akaza H Gan To Kagaku Ryoho; 1998 Feb; 25(3):345-51. PubMed ID: 9492827 [TBL] [Abstract][Full Text] [Related]
15. [Determination of surface ABO(H) isoantigens in transitional cell carcinoma of the bladder. Clinicopathological study. (Part 1)]. Gelabert Mas A; Corominas J; Arango O Actas Urol Esp; 1988; 12(3):248-53. PubMed ID: 3177059 [No Abstract] [Full Text] [Related]
16. Biochemical and immunologic diagnosis of cancer. Colorectal cancer. von Kleist S Tumour Biol; 1987; 8(2-3):78-83. PubMed ID: 3329404 [No Abstract] [Full Text] [Related]
17. [Conservation or loss of membrane antigens of the ABH blood group and their precursor substance. Prognostic importance for tumors of the bladder]. Hammou JC; Fella C; Vacant J Acta Urol Belg; 1983; 51(1):12-7. PubMed ID: 6858793 [No Abstract] [Full Text] [Related]
19. Immunohistochemical markers in the evaluation of tumors of the urinary bladder: a review. Requena MJ; Alvarez-Kindelan J; Blanca A Anal Quant Cytol Histol; 2007 Dec; 29(6):380-2. PubMed ID: 18225396 [No Abstract] [Full Text] [Related]
20. Biochemical and immunologic diagnosis of cancer. Breast cancer. Neville AM; Coombes RC Tumour Biol; 1987; 8(2-3):116-9. PubMed ID: 3448762 [No Abstract] [Full Text] [Related] [Next] [New Search]